Nevertheless, the infiltration of CD4+ and CD8+ T cells within tumors increased after anlotinib therapy (Fig. 6b, d, e), consistent with a previous report.47 To further evaluate the change in immune response within tumors, we examined the concentrations of various chemokines and cytokines in tumor homogenates. This evidence concerns the gene CD8A and neoplasm.